Erolabs Pharmaceuticals Private Limited
About Erolabs Pharmaceuticals Private Limited
Data last updated:
Erolabs Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2019PTC319296. Its GSTIN is 09AAFCE3279D1ZM (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Akhil Kumar Jaiswal and Gurmeet Kaur.
Its last annual general meeting (AGM) was held on 28 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 601 Wing – A1 Hira Manik Ovala Godbhandar Road Behind Mahindra Showroom, Thane, Maharashtra, India – 400607.
As per the financials filed for FY 2022, the company reported a revenue of ₹6.43 Lakh, a decline of 76% compared to the previous year. For the same year it recorded a net loss of ₹158 (net margin 0%) and EBITDA of -₹4,364 (EBITDA margin -0.7%).
As per MCA filings, the company has open charges of ₹24.4 Lakh on record.
Company details
Contact details
Erolabs Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered Address601 Wing – A1 Hira Manik Ovala Godbhandar Road Behind Mahindra Showroom, Thane, Maharashtra, India – 400607
- IndustryChemicals, Manufacturing, Other Chemical Product, Fine Chemicals And Other Chemical Products
To see the full contact details of Erolabs Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Erolabs Pharmaceuticals Private Limited
FY 2023 filings availableErolabs Pharmaceuticals Private Limited reported revenue of ₹6.43 Lakh (down 76% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 76% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹6.43 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹4,364 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹158 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.7% | |||
| Net Profit Margin | 0% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Erolabs Pharmaceuticals Private Limited, buy the company report.
Board of directors of Erolabs Pharmaceuticals Private Limited
Erolabs Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akhil Kumar Jaiswal | Director | 09 Jan 2019 | 7 Years 9 Months | Current |
| Gurmeet Kaur | Director | 09 Jan 2019 | 7 Years 9 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 Mar 2020 | 100364739 | Others | ₹24.4 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Erolabs Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Erolabs Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Erolabs Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCE3279D1ZM | Uttar Pradesh | Active | 08 Oct 2019 |
To see the full GST registrations and return filing status of Erolabs Pharmaceuticals Private Limited, buy the company report.
Recent activity
Erolabs Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Akhil Kumar Jaiswal was appointed as Director on 09 Jan 2019.
Frequently asked questions
Erolabs Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 January 2019 (7+ years old) and is registered under CIN U24299MH2019PTC319296.
Erolabs Pharmaceuticals has 2 current directors:
- Akhil Kumar Jaiswal - Director
- Gurmeet Kaur - Director
The latest financial statements of Erolabs Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 28 September 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Erolabs Pharmaceuticals is 09AAFCE3279D1ZM, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Erolabs Pharmaceuticals is U24299MH2019PTC319296. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Erolabs Pharmaceuticals was incorporated on 09 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Akhil Kumar Jaiswal was appointed as Director on 09 Jan 2019. Gurmeet Kaur was appointed as Director on 09 Jan 2019.
The registered office of Erolabs Pharmaceuticals is at 601 Wing – A1 Hira Manik Ovala Godbhandar Road Behind Mahindra Showroom, Thane, Maharashtra, India – 400607.
Erolabs Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Erolabs Pharmaceuticals has open charges of ₹24.4 Lakh and no satisfied charges on record as per latest MCA filings.